FULCRUM THERAPEUTICS, INC. Basic Shares Outstanding (Weighted Average)
FULCRUM THERAPEUTICS, INC. (FULC) reported Basic Shares Outstanding (Weighted Average) of 76.26 million shares for the 3-month period ending 2026-06-30, per its S-4 filed 2026-09-02.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-09-02
- FULCRUM THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 76.26M shares, a 21.94% increase year-over-year.
- FULCRUM THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 76.22M shares, a 21.98% increase year-over-year.
- FULCRUM THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 65.81M shares, a 7.29% increase year-over-year.
- FULCRUM THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 62.60M shares, a 0.30% increase year-over-year.
- FULCRUM THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 61.31K shares, a 36.27% increase from fiscal 2022.
- FULCRUM THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 44.99K shares, a 27.23% increase from fiscal 2021.
- FULCRUM THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2021 was 35.36K shares, a 39.47% increase from fiscal 2020.
- FULCRUM THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2020 was 25.35K shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 76.26M shares S-4 · filed 2026-09-02 | 76.24M shares S-4 · filed 2026-09-02 | 72.76M shares derived: average of 3 quarters · filed 2026-09-02 | 70.22M shares derived: average of 4 quarters · filed 2026-09-02 | ||||
| 2026-03-31 | 76.22M shares 10-Q · filed 2026-04-27 | 71.01M shares derived: average of 2 quarters · filed 2026-09-02 | 68.21M shares derived: average of 3 quarters · filed 2026-09-02 | 66.79M shares derived: average of 4 quarters · filed 2026-09-02 | ||||
| 2025-12-31 | 65.81M shares derived: S-4 12 month − 10-Q 9 month · filed 2026-09-02 | 64.20M shares derived: average of 2 quarters · filed 2026-09-02 | 63.65M shares derived: average of 3 quarters · filed 2026-09-02 | 63.35M shares S-4 · filed 2026-09-02 | 63.35K shares 10-K · filed 2026-02-24 | |||
| 2025-09-30 | 62.60M shares 10-Q · filed 2025-10-29 | 62.57M shares derived: average of 2 quarters · filed 2026-09-02 | 62.54M shares 10-Q · filed 2025-10-29 | 62.24M shares derived: average of 4 quarters · filed 2026-09-02 | ||||
| 2025-06-30 | 62.54M shares S-4 · filed 2026-09-02 | 62.51M shares S-4 · filed 2026-09-02 | 62.12M shares derived: average of 3 quarters · filed 2026-09-02 | 62.19M shares derived: average of 4 quarters · filed 2026-09-02 | ||||
| 2025-03-31 | 62.48M shares 10-Q · filed 2026-04-27 | 61.91M shares derived: average of 2 quarters · filed 2026-09-02 | 62.07M shares derived: average of 3 quarters · filed 2026-09-02 | 62.11M shares derived: average of 4 quarters · filed 2026-09-02 | ||||
| 2024-12-31 | 61.34M shares derived: S-4 12 month − 10-Q 9 month · filed 2026-09-02 | 61.87M shares derived: average of 2 quarters · filed 2026-09-02 | 61.98M shares derived: average of 3 quarters · filed 2026-09-02 | 61.98M shares S-4 · filed 2026-09-02 | 61.98K shares 10-K · filed 2025-02-25 | |||
| 2024-09-30 | 62.41M shares 10-Q · filed 2025-10-29 | 62.31M shares derived: average of 2 quarters · filed 2025-10-29 | 62.20M shares 10-Q · filed 2025-10-29 | 870.06K shares derived: average of 4 quarters · filed 2025-10-29 | ||||
| 2024-06-30 | 62.20M shares 10-Q · filed 2025-07-29 | 62.09M shares 10-Q · filed 2025-07-29 | -19.64M shares derived: average of 3 quarters · filed 2025-07-29 | 723.56K shares derived: average of 4 quarters · filed 2025-07-29 | ||||
| 2024-03-31 | 61.98M shares 10-Q · filed 2025-05-01 | 61.98K shares 10-Q · filed 2024-05-13 | -60.57M shares derived: average of 2 quarters · filed 2025-05-01 | -19.77M shares derived: average of 3 quarters · filed 2025-05-01 | 620.81K shares derived: average of 4 quarters · filed 2025-05-01 | |||
| 2023-12-31 | -183.12M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -60.65M shares derived: average of 2 quarters · filed 2025-02-25 | -19.83M shares derived: average of 3 quarters · filed 2025-02-25 | 61.31K shares 10-K · filed 2025-02-25 | ||||
| 2023-09-30 | 61.82M shares 10-Q · filed 2024-11-13 | 61.82K shares 10-Q · filed 2023-11-07 | 61.81M shares derived: average of 2 quarters · filed 2024-11-13 | 61.12M shares 10-Q · filed 2024-11-13 | 61.12K shares 10-Q · filed 2023-11-07 | 30.93M shares derived: average of 4 quarters · filed 2024-11-13 | ||
| 2023-06-30 | 61.79M shares 10-Q · filed 2024-07-31 | 61.79K shares 10-Q · filed 2023-08-03 | 60.76M shares 10-Q · filed 2024-07-31 | 60.76K shares 10-Q · filed 2023-08-03 | 20.64M shares derived: average of 3 quarters · filed 2024-07-31 | 15.49M shares derived: average of 4 quarters · filed 2024-07-31 | ||
| 2023-03-31 | 59.72K shares 10-Q · filed 2024-05-13 | 55.94K shares derived: average of 2 quarters · filed 2024-05-13 | 52.70K shares derived: average of 3 quarters · filed 2024-05-13 | 49.74K shares derived: average of 4 quarters · filed 2024-05-13 | ||||
| 2022-12-31 | 52.16K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | 49.18K shares derived: average of 2 quarters · filed 2024-02-27 | 46.42K shares derived: average of 3 quarters · filed 2024-02-27 | 44.99K shares 10-K · filed 2024-02-27 | ||||
| 2022-09-30 | 46.21K shares 10-Q · filed 2023-11-07 | 43.55K shares derived: average of 2 quarters · filed 2023-11-07 | 42.60K shares 10-Q · filed 2023-11-07 | 42.10K shares derived: average of 4 quarters · filed 2023-11-07 | ||||
| 2022-06-30 | 40.89K shares 10-Q · filed 2023-08-03 | 40.77K shares 10-Q · filed 2023-08-03 | 40.72K shares derived: average of 3 quarters · filed 2023-08-03 | 39.69K shares derived: average of 4 quarters · filed 2023-08-03 | ||||
| 2022-03-31 | 40.64K shares 10-Q · filed 2023-05-15 | 40.64K shares derived: average of 2 quarters · filed 2023-06-26 | 39.30K shares derived: average of 3 quarters · filed 2023-06-26 | 37.63K shares derived: average of 4 quarters · filed 2023-06-26 | ||||
| 2021-12-31 | 40.63K shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-26 | 38.62K shares derived: average of 2 quarters · filed 2023-06-26 | 36.63K shares derived: average of 3 quarters · filed 2023-06-26 | 35.36K shares 10-K/A · filed 2023-06-26 | ||||
| 2021-09-30 | 36.61K shares 10-Q · filed 2022-11-08 | 34.62K shares derived: average of 2 quarters · filed 2022-11-08 | 33.60K shares 10-Q · filed 2022-11-08 | |||||
| 2021-06-30 | 32.64K shares 10-Q · filed 2022-08-11 | 32.08K shares 10-Q · filed 2022-08-11 | ||||||
| 2020-12-31 | 25.35K shares 10-K/A · filed 2023-06-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |